Сell-free pertussis vaccine from antigens of freshly isolated strain of B. pertussis serotype 1.2.3
Aim. Development of technology for the manufacture of cell-free pertussis vaccine (CPV) from a freshly isolated strain of B. pertussis No. 211 serotype 1.2.3 and the study of its protective activity and safety in comparison with the preparation of vaccine strains. Materials and methods. Following B....
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Central Research Institute for Epidemiology
2020-05-01
|
Series: | Журнал микробиологии, эпидемиологии и иммунобиологии |
Subjects: | |
Online Access: | https://microbiol.elpub.ru/jour/article/view/776 |